• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于聚甘油甲基丙烯酸酯的可降解纳米颗粒用于递送小干扰 RNA。

Poly(glycerol methacrylate)-based degradable nanoparticles for delivery of small interfering RNA.

机构信息

a Assiut International Center of Nanomedicine , Al-Rajhy Liver Hospital, Assiut University , Assiut , Egypt.

b Department of Surgery, Faculty of Medicine , Assiut University , Assiut , Egypt.

出版信息

Pharm Dev Technol. 2018 Apr;23(4):387-399. doi: 10.1080/10837450.2017.1312443. Epub 2017 Apr 7.

DOI:10.1080/10837450.2017.1312443
PMID:28347210
Abstract

Nucleic acids therapeutic efficiency is generally limited by their low stability and intracellular bioavailability, and by the toxicity of the carriers used to deliver them to the target sites. Aminated poly(glycerol methacrylate) polymers are biodegradable and pH-sensitive polymers that have been used previously to deliver antisense oligonucleotide and show high transfection efficiency. The purpose of this study is to compare the efficiency and toxicity of aminated linear poly(glycerol methacrylate) (ALT) biodegradable polymer to the most commonly used cationic degradable (i.e. chitosan) and non-degradable (i.e. polyethylenimine (PEI)) polymers for delivery of short interfering RNA (siRNA). ALT, PEI and chitosan polymers were able to form nanosized particles with siRNA. Size, size-distribution and zeta-potential were measured over a wide range of nitrogen-to-phosphate (N/P) ratios, and the stability of the formed nanoparticles in saline and upon freeze-drying was also assessed. No significant cytotoxicity at the range of the tested concentrations of ALT and chitosan nanoparticles was observed, whereas the non-degradable PEI showed significant toxicity in huh-7 hepatocyte-derived carcinoma cell line. The safety profiles of the degradable polymers (ALT and chitosan) over non-degradable PEI were demonstrated in vitro and in vivo. In addition, ALT nanoparticles were able to deliver siRNA in vivo with significantly higher efficiency than chitosan nanoparticles. The results in the present study give evidence of the great implications of ALT nanoparticles in biomedical applications due to their biocompatibility, low cytotoxicity, high stability and simple preparation method.

摘要

核酸治疗的效率通常受到其低稳定性和细胞内生物利用度的限制,以及用于将其递送到靶部位的载体的毒性的限制。氨基化聚(甘油甲基丙烯酸酯)聚合物是可生物降解和 pH 敏感的聚合物,以前曾用于递送反义寡核苷酸,并显示出高转染效率。本研究的目的是比较氨基化线性聚(甘油甲基丙烯酸酯)(ALT)可生物降解聚合物与最常用的阳离子可降解(即壳聚糖)和不可降解(即聚乙烯亚胺(PEI))聚合物在递送短干扰 RNA(siRNA)方面的效率和毒性。ALT、PEI 和壳聚糖聚合物能够与 siRNA 形成纳米级颗粒。在广泛的氮-磷(N/P)比范围内测量了粒径、粒径分布和 zeta 电位,并评估了形成的纳米颗粒在盐水中和冷冻干燥时的稳定性。在测试浓度范围内,ALT 和壳聚糖纳米颗粒没有观察到明显的细胞毒性,而不可降解的 PEI 在 huh-7 肝癌衍生癌细胞系中表现出明显的毒性。可降解聚合物(ALT 和壳聚糖)在体外和体内的安全性概况均优于不可降解的 PEI。此外,ALT 纳米颗粒能够在体内以比壳聚糖纳米颗粒更高的效率递送 siRNA。本研究的结果证明了 ALT 纳米颗粒在生物医学应用中的重要意义,因为它们具有生物相容性、低细胞毒性、高稳定性和简单的制备方法。

相似文献

1
Poly(glycerol methacrylate)-based degradable nanoparticles for delivery of small interfering RNA.基于聚甘油甲基丙烯酸酯的可降解纳米颗粒用于递送小干扰 RNA。
Pharm Dev Technol. 2018 Apr;23(4):387-399. doi: 10.1080/10837450.2017.1312443. Epub 2017 Apr 7.
2
Biodegradable poly(ester amine) based on glycerol dimethacrylate and polyethylenimine as a gene carrier.基于甘油二甲基丙烯酸酯和聚乙烯亚胺的可生物降解聚(酯胺)作为基因载体。
J Gene Med. 2008 Nov;10(11):1223-35. doi: 10.1002/jgm.1252.
3
Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.评价可生物降解共聚物的阳离子纳米颗粒作为治疗乙型肝炎的 siRNA 递送系统。
Int J Pharm. 2010 Nov 15;400(1-2):194-200. doi: 10.1016/j.ijpharm.2010.08.026. Epub 2010 Aug 27.
4
Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.用于荷瘤小鼠体内 siRNA 系统递送的肿瘤归巢性乙二醇壳聚糖/聚乙烯亚胺纳米粒。
J Control Release. 2010 Jun 1;144(2):134-43. doi: 10.1016/j.jconrel.2010.02.023. Epub 2010 Feb 22.
5
Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.细胞内可裂解的聚(2-二甲氨基乙基甲基丙烯酸酯)功能化介孔硅纳米粒子用于体外和体内高效 siRNA 递送。
Nanoscale. 2013 May 21;5(10):4291-301. doi: 10.1039/c3nr00294b.
6
Structural contributions of blocked or grafted poly(2-dimethylaminoethyl methacrylate) on PEGylated polycaprolactone nanoparticles in siRNA delivery.受阻或接枝聚(2-二甲氨基乙基甲基丙烯酸酯)对聚乙二醇化聚己内酯纳米粒在 siRNA 递送中的结构贡献。
Biomaterials. 2011 Nov;32(33):8730-42. doi: 10.1016/j.biomaterials.2011.07.089. Epub 2011 Sep 1.
7
Photoluminescent and biodegradable polycitrate-polyethylene glycol-polyethyleneimine polymers as highly biocompatible and efficient vectors for bioimaging-guided siRNA and miRNA delivery.具有光致发光和可生物降解性的聚柠檬酸盐-聚乙二醇-聚乙烯亚胺聚合物作为高度生物相容性和高效的载体,用于生物成像引导的 siRNA 和 miRNA 递送。
Acta Biomater. 2017 May;54:69-80. doi: 10.1016/j.actbio.2017.02.034. Epub 2017 Feb 20.
8
Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA.聚磷酸酯纳米颗粒作为用于递送多种药物和小干扰RNA的可生物降解平台。
Drug Des Devel Ther. 2017 Feb 22;11:483-496. doi: 10.2147/DDDT.S128503. eCollection 2017.
9
Comparative analysis of polymers for short interfering RNA delivery in vascular smooth muscle cells.用于血管平滑肌细胞中短干扰RNA递送的聚合物的比较分析
J Surg Res. 2015 Nov;199(1):266-73. doi: 10.1016/j.jss.2015.07.025. Epub 2015 Jul 17.
10
Lyophilised ready-to-use formulations of PEG-PCL-PEI nano-carriers for siRNA delivery.用于 siRNA 递送的 PEG-PCL-PEI 纳米载体的冻干即用型制剂。
Int J Pharm. 2012 May 30;428(1-2):121-4. doi: 10.1016/j.ijpharm.2012.03.003. Epub 2012 Mar 10.

引用本文的文献

1
Development of Fully Degradable Phosphonium-Functionalized Amphiphilic Diblock Copolymers for Nucleic Acids Delivery.用于核酸递送的完全可降解的膦功能化两亲性嵌段共聚物的开发。
Biomacromolecules. 2018 Apr 9;19(4):1212-1222. doi: 10.1021/acs.biomac.8b00069. Epub 2018 Mar 11.
2
Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA.聚磷酸酯纳米颗粒作为用于递送多种药物和小干扰RNA的可生物降解平台。
Drug Des Devel Ther. 2017 Feb 22;11:483-496. doi: 10.2147/DDDT.S128503. eCollection 2017.